
The N.1 Institute for Health (N.1) is a research and development organization focused on translating medical innovations from the lab to the clinic. They specialize in N-of-1 medicine, digital health and therapeutics, augmented cognition and training, and robotics. N.1 leverages platforms like CURATE.AI to conduct first-in-human trials, with a stated objective of deploying interventional, Institute-driven technologies. The institute has initiated multiple clinical studies, some of which have reportedly resulted in life-saving outcomes. Their work spans areas such as AI-driven cancer therapy, neuroengineering, and developing theranostic devices for conditions like chemotherapy-induced neuropathy. N.1 emphasizes policy and education to scale the deployment of their technologies.

The N.1 Institute for Health (N.1) is a research and development organization focused on translating medical innovations from the lab to the clinic. They specialize in N-of-1 medicine, digital health and therapeutics, augmented cognition and training, and robotics. N.1 leverages platforms like CURATE.AI to conduct first-in-human trials, with a stated objective of deploying interventional, Institute-driven technologies. The institute has initiated multiple clinical studies, some of which have reportedly resulted in life-saving outcomes. Their work spans areas such as AI-driven cancer therapy, neuroengineering, and developing theranostic devices for conditions like chemotherapy-induced neuropathy. N.1 emphasizes policy and education to scale the deployment of their technologies.